银诺医药-B(02591)发布公告，于2025年10月14日，公司及银诺技术(公司一间直接全资附属公司)以代价 合共人民币1.05亿元(即其总本金额)向宁波银行认购一项银行结构性存款产品。 ...

格隆汇10月14日丨银诺医药-B(02591.HK)宣布，于2025年10月14日，公司及银诺技术(公司一间直接全 资附属公司)以代价合共人民币1.05亿元(即其总本金额)向宁波银行认购一项银行结构性存款产品。 来源：格隆汇APP ...

智通财经APP讯，银诺医药-B(02591)发布公告，于2025年10月14日，公司及银诺技术(公司一间直接全 资附属公司)以代价合共人民币1.05亿元(即其总本金额)向宁波银行认购一项银行结构性存款产品。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603237 证券简称：五芳斋 公告编号：2025-076 浙江五芳斋实业股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 ● 投资种类：银行结构性存款产品 ● 投资金额：人民币15,000.00万元 ● 履行的审议程序：浙江五芳斋实业股份有限公司（以下简称"公司"）于2025年4月15日召开了第九届 董事会第十九次会议和第九届监事会第十四次会议，审议通过了《关于使用部分闲置募集资金进行现金 管理的议案》，同意公司在确保不影响募集资金投资项目正常进行的前提下，使用额度不超过人民币 20,000.00万元的部分闲置募集资金进行现金管理，有效期为自公司董事会审议通过之日起12个月内有 效。在上述额度及决议有效期内，可循环滚动使用，期限内任一时点的交易金额（含前述投资的收益进 行再投资的相关金额）不超过上述额度。公司董事会授权公司董事长或董事长授权人士在额度范围内行 使该项投资决策权并签署相关 ...

Group 1 - The stock price of Wangfujing (600859) closed at 13.67 yuan on June 27, 2025, down 0.44% with a turnover rate of 1.23% and a trading volume of 138,500 shares, amounting to a transaction value of 190 million yuan [1] - On June 27, 2025, the capital flow for Wangfujing showed a net outflow of 28.0167 million yuan from main funds, accounting for 14.77% of the total transaction value, while retail investors had a net inflow of 14.4725 million yuan, representing 7.63% of the total transaction value [2][4] - The company's board of directors approved the use of up to 1.5 billion yuan of idle self-owned funds to purchase structured deposit products, with a daily balance limit of 1.5 billion yuan, and the authorization is valid for 12 months from the date of approval [2][4] Group 2 - Wangfujing announced an adjustment to the total cash dividend for the 2024 profit distribution, reducing it from 90,058,625.92 yuan to 89,914,513.92 yuan (including tax), due to the completion of the repurchase and cancellation of 11,118,027 shares, changing the total share capital from 1,135,049,451 shares to 1,123,931,424 shares [3]

Core Viewpoint - The company has approved the use of idle raised funds for cash management, specifically investing up to RMB 650 million in low-risk, high-security structured deposit products to enhance fund efficiency and returns for shareholders [1][2][3]. Group 1: Cash Management Product Redemption - The company purchased a structured deposit product from Industrial and Commercial Bank of China (ICBC) on May 30, 2024, with a total investment of RMB 650 million, which matured on May 19, 2025, yielding a total return of RMB 15,697,232.88 [2][3]. - The investment was fully recovered without any overdue amounts, and the funds were returned to the designated account for raised funds [2][3]. Group 2: Fundraising and Investment Purpose - The company raised a total of RMB 2,711.70 million through an initial public offering, with a net amount of RMB 2,620.05 million after deducting issuance costs [3]. - The purpose of using idle funds for cash management is to improve fund efficiency and increase returns without affecting the construction of investment projects [3][4]. Group 3: Investment Details - The total amount allocated for cash management is RMB 650 million, which is the maximum limit set for such investments [4]. - The structured deposit product has a maturity date of May 19, 2026, and is designed to be low-risk with a guaranteed principal [4][5]. Group 4: Risk Management - The structured deposit products are classified as low-risk investments with high security and liquidity, and the company has implemented measures to monitor and manage potential risks [5]. - The management team is responsible for overseeing the cash management products, with the finance department analyzing and tracking the investment's performance [5]. Group 5: Impact on the Company - The cash management initiative is expected to enhance fund efficiency and provide better returns to shareholders without significantly impacting the company's main business or financial status [6]. - The cash management investment represents 10.75% of the company's cash at the end of the most recent reporting period [6].